|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.36 USD | -1.09% |
|
+3.13% | +37.08% |
| Apr. 03 | XOMA Corporation completed the acquisition of Kinnate Biopharma Inc.. | CI |
| Mar. 08 | XOMA Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
XOMA Corporation reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported revenue was USD 35.94 million compared to USD 27.58 million a year ago. Net income was USD 29.84 million compared to USD 22.67 million a year ago.
Basic earnings per share from continuing operations was USD 1.75 compared to USD 1.4 a year ago. Diluted earnings per share from continuing operations was USD 1.67 compared to USD 1.32 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +37.08% | 298M | |
| -2.26% | 104B | |
| +1.41% | 97.42B | |
| +0.79% | 22.2B | |
| -17.84% | 21.23B | |
| -11.11% | 18.33B | |
| -42.83% | 16.35B | |
| -17.63% | 15.06B | |
| +4.55% | 13.98B | |
| +32.11% | 11.66B |
XOMA CORPORATION 
